{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:01:00Z","timestamp":1793952060027,"version":"4.8.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Biomedical Research Centre Funding Scheme"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Myositis UK"},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21993"],"award-info":[{"award-number":["21993"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Manchester Biomedical Research Centre"},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"name":"Bath Institute of Rheumatic Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify clinical factors associated with cancer risk in the idiopathic inflammatory myopathies (IIMs) and to systematically review the existing evidence related to cancer screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was carried out on Medline, Embase and Scopus. Cancer risk within the IIM population (i.e. not compared with the general population) was expressed as risk ratios (RR) for binary variables and weighted mean differences (WMD) for continuous variables. Evidence relating to cancer screening practices in the IIMs were synthesized via narrative review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-nine studies were included in the meta-analysis. DM subtype (RR 2.21), older age (WMD 11.19), male sex (RR 1.53), dysphagia (RR 2.09), cutaneous ulceration (RR 2.73) and anti-transcriptional intermediary factor-1 gamma positivity (RR 4.66) were identified as being associated with significantly increased risk of cancer. PM (RR 0.49) and clinically amyopathic DM (RR 0.44) subtypes, Raynaud\u2019s phenomenon (RR 0.61), interstitial lung disease (RR 0.49), very high serum creatine kinase (WMD \u22121189.96) or lactate dehydrogenase (WMD \u2212336.52) levels, and anti-Jo1 (RR 0.45) or anti-EJ (RR 0.17) positivity were identified as being associated with significantly reduced risk of cancer. Nine studies relating to IIM-specific cancer screening were included. CT scanning of the thorax, abdomen and pelvis appeared to be effective in identifying underlying asymptomatic cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cancer risk factors should be evaluated in patients with IIM for risk stratification. Screening evidence is limited but CT scanning could be useful. Prospective studies and consensus guidelines are needed to establish cancer screening strategies in IIM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab166","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T16:24:47Z","timestamp":1613492687000},"page":"2615-2628","source":"Crossref","is-referenced-by-count":144,"title":["A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-6490","authenticated-orcid":false,"given":"Alexander G S","family":"Oldroyd","sequence":"first","affiliation":[{"name":"National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK"},{"name":"Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B","family":"Allard","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P","family":"Callen","sequence":"additional","affiliation":[{"name":"Division of Medicine, Department of Medicine, University of Louisville, Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1288","authenticated-orcid":false,"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine and Dermatology, Stanford University, Stanford, USA"},{"name":"Palo Alto Health Care System, Palo Alto, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"George","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Philadelphia, PA, USA"},{"name":"Division of Epidemiology, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Kolstad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew J B","family":"Kurtzman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wright State University, Dayton, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK"},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Trust, London, UK"},{"name":"Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-658X","authenticated-orcid":false,"given":"Neil J","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmacology, University of Bath, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Postolova","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Stanford Health Care, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Selva-O\u2019Callaghan","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Unity, Vall D\u2019Hebron General Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neuromuscular Centre, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-9598","authenticated-orcid":false,"given":"Sarah","family":"Tansley","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK"},{"name":"Department of Neurology, Neuromuscular Centre, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA, USA"},{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P","family":"Werth","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia, USA"},{"name":"Division of Dermatology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-8038","authenticated-orcid":false,"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"2021061821300696600_keab166-B1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd","year":"2017","journal-title":"Clin Med (Northfield IL)"},{"key":"2021061821300696600_keab166-B2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/med\/9780199642489.003.0124_update_002","volume-title":"Oxford Textbook of Rheumatology","author":"Chinoy","year":"2013"},{"key":"2021061821300696600_keab166-B3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta-analysis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"2021061821300696600_keab166-B4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2021061821300696600_keab166-B5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00296-017-3799-x","article-title":"Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain","volume":"37","author":"Nu\u00f1o-Nu\u00f1o","year":"2017","journal-title":"Rheumatol Int"},{"key":"2021061821300696600_keab166-B6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.rdc.2020.05.006","article-title":"Risk factors and cancer screening in myositis","volume":"46","author":"Moghadam-Kia","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"2021061821300696600_keab166-B8","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2021061821300696600_keab166-B9","volume-title":"SIGN 50. A guideline developer\u2019s handbook","year":"2011"},{"key":"2021061821300696600_keab166-B10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2021061821300696600_keab166-B11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"2021061821300696600_keab166-B12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"key":"2021061821300696600_keab166-B13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"2021061821300696600_keab166-B14","volume-title":"R: A language and environment for statistical computing","year":"2014"},{"key":"2021061821300696600_keab166-B15","first-page":"1","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume-title":"Evid Based Ment Health","author":"Balduzzi","year":"2019"},{"key":"2021061821300696600_keab166-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analysis in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"2021061821300696600_keab166-B17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br J Dermatol"},{"key":"2021061821300696600_keab166-B18","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021061821300696600_keab166-B19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br J Dermatol"},{"key":"2021061821300696600_keab166-B20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"2021061821300696600_keab166-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2021061821300696600_keab166-B22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3899\/jrheum.110320","article-title":"Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis","volume":"38","author":"So","year":"2011","journal-title":"J Rheumatol"},{"key":"2021061821300696600_keab166-B23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"2021061821300696600_keab166-B24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/14397595.2015.1054081","article-title":"Long-term follow-up of 124 patients with polymyositis and dermatomyositis: statistical analysis of prognostic factors","volume":"26","author":"Ishizuka","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2021061821300696600_keab166-B25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00296-013-2910-1","article-title":"Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort","volume":"34","author":"Neri","year":"2014","journal-title":"Rheumatol Int"},{"key":"2021061821300696600_keab166-B26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis","volume":"21","author":"Azuma","year":"2011","journal-title":"Mod Rheumatol"},{"key":"2021061821300696600_keab166-B27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0028-3886.111121","article-title":"Incidence of malignancies in biopsy-proven inflammatory myopathy","volume":"61","author":"Meena","year":"2013","journal-title":"Neurol India"},{"key":"2021061821300696600_keab166-B28","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J Rheumatol"},{"key":"2021061821300696600_keab166-B29","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"35","author":"Fang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2021061821300696600_keab166-B30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol Int"},{"key":"2021061821300696600_keab166-B31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2474-11-223","article-title":"Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis","volume":"11","author":"Kang","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"2021061821300696600_keab166-B32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","article-title":"Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis","volume":"55","author":"Kang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821300696600_keab166-B33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3904\/kjim.2014.29.6.814","article-title":"Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy","volume":"29","author":"Kim","year":"2014","journal-title":"Korean J Intern Med"},{"key":"2021061821300696600_keab166-B34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","article-title":"Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study","volume":"41","author":"Wakata","year":"2002","journal-title":"Int J Dermatol"},{"key":"2021061821300696600_keab166-B35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40064-015-1013-8","article-title":"Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study","volume":"4","author":"Ikeda","year":"2015","journal-title":"Springerplus"},{"key":"2021061821300696600_keab166-B36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(98)80052-8","article-title":"High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis","volume":"27","author":"Maoz","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"2021061821300696600_keab166-B37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10067-016-3453-0","article-title":"Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis","volume":"36","author":"Ceribelli","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2021061821300696600_keab166-B38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3349\/ymj.2006.47.4.519","article-title":"Malignancies in Korean patients with inflammatory myopathy","volume":"47","author":"Lee","year":"2006","journal-title":"Yonsei Med J"},{"key":"2021061821300696600_keab166-B39","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s12253-019-00756-4","article-title":"Retrospective analysis of cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort","volume":"26","author":"Andr\u00e1s","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"2021061821300696600_keab166-B40","doi-asserted-by":"crossref","first-page":"205031211878189","DOI":"10.1177\/2050312118781895","article-title":"The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis\/polymyositis patients: a retrospective study","volume":"6","author":"Lim","year":"2018","journal-title":"SAGE Open Med"},{"key":"2021061821300696600_keab166-B41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","article-title":"Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients","volume":"38","author":"Ikeda","year":"2011","journal-title":"J Dermatol"},{"key":"2021061821300696600_keab166-B42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-\u03b3 antibody and cancer-associated myositis","volume":"87","author":"Hida","year":"2016","journal-title":"Neurology"},{"key":"2021061821300696600_keab166-B44","first-page":"990","article-title":"Strong correlation between cancer progression and anti-transcription intermediary factor 1\u03b3 antibodies in dermatomyositis patients","volume":"36","author":"Ogawa-Momohara","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821300696600_keab166-B45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"2021061821300696600_keab166-B46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2021061821300696600_keab166-B47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore"},{"key":"2021061821300696600_keab166-B48","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-\u03b3 antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"key":"2021061821300696600_keab166-B49","first-page":"713","article-title":"Newly diagnosed dermatomyositis in the elderly as predictor of malignancy","volume":"52","author":"Souza FHC","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"2021061821300696600_keab166-B50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/bjd.14227","article-title":"Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort","volume":"174","author":"Galimberti","year":"2016","journal-title":"Br J Dermatol"},{"key":"2021061821300696600_keab166-B51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000051611","article-title":"Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy","volume":"202","author":"Hunger","year":"2001","journal-title":"Dermatology"},{"key":"2021061821300696600_keab166-B52","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mjd.2002.120620","article-title":"Amyopathic dermatomyositis: retrospective review of 37 cases","volume":"46","author":"El-Azhary","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"2021061821300696600_keab166-B53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"2021061821300696600_keab166-B54","doi-asserted-by":"crossref","first-page":"843","DOI":"10.47102\/annals-acadmedsg.V39N11p843","article-title":"An 11-year review of dermatomyositis in Asian patients","volume":"39","author":"Liu","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"2021061821300696600_keab166-B55","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1097-0142(19841101)54:9<1841::AID-CNCR2820540912>3.0.CO;2-K","article-title":"Cancer in collagen disease. A statistical analysis by reviewing the annual of pathological autopsy cases (Nippon Boken Shuho) in Japan","volume":"54","author":"Okayasu","year":"1984","journal-title":". Cancer"},{"key":"2021061821300696600_keab166-B56","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B57","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.40895","article-title":"The IgG2 isotype of anti-transcription intermediary factor 1\u03b3 autoantibodies is a biomarker of cancer and mortality in adult dermatomyositis","volume":"71","author":"Aussy","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021061821300696600_keab166-B58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"key":"2021061821300696600_keab166-B59","first-page":"5960","article-title":"Characteristics and predictors of malignancy in dermatomyositis: analysis of 239 patients from northern China","volume":"16","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"key":"2021061821300696600_keab166-B60","doi-asserted-by":"crossref","first-page":"e0154746","DOI":"10.1371\/journal.pone.0154746","article-title":"Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies","volume":"11","author":"Mugii","year":"2016","journal-title":"PLoS One"},{"key":"2021061821300696600_keab166-B61","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021061821300696600_keab166-B62","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","article-title":"The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"38","author":"Li","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021061821300696600_keab166-B63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2021061821300696600_keab166-B64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jdermsci.2016.09.013","article-title":"Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis","volume":"84","author":"Fujimoto","year":"2016","journal-title":"J Dermatol Sci"},{"key":"2021061821300696600_keab166-B65","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2011-200871","article-title":"Anti-TIF1\u03b3 antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays","volume":"71","author":"Labrador-Horrillo","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","article-title":"Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy","volume":"89","author":"Trallero-Aragu\u00e1s","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"2021061821300696600_keab166-B68","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jdv.14759","article-title":"Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients","volume":"32","author":"Best","year":"2018","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"2021061821300696600_keab166-B69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology"},{"key":"2021061821300696600_keab166-B70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009740802687455","article-title":"Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectiona","volume":"38","author":"Fujikawa","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"2021061821300696600_keab166-B71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"key":"2021061821300696600_keab166-B72","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2021061821300696600_keab166-B73","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021061821300696600_keab166-B74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","article-title":"Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2","volume":"51","author":"Ishikawa","year":"2012","journal-title":"Rheumatology (United Kingdom)"},{"key":"2021061821300696600_keab166-B75","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2021061821300696600_keab166-B76","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s10067-018-4216-x","article-title":"Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2021061821300696600_keab166-B77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2021061821300696600_keab166-B78","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821300696600_keab166-B79","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"2021061821300696600_keab166-B80","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"2021061821300696600_keab166-B81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03009742.2019.1672782","article-title":"Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level","volume":"49","author":"Aggarwal","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"2021061821300696600_keab166-B82","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaad.2018.11.023","article-title":"Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis","volume":"80","author":"Hoesly","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2021061821300696600_keab166-B83","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.3748\/wjg.v23.i26.4788","article-title":"Endoscopy is of low yield in the identification of gastrointestinal neoplasia in patients with dermatomyositis: a cross-sectional study","volume":"23","author":"Kidambi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2021061821300696600_keab166-B84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl Med Commun"},{"key":"2021061821300696600_keab166-B85","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2021061821300696600_keab166-B86","doi-asserted-by":"crossref","first-page":"e0181069","DOI":"10.1371\/journal.pone.0181069","article-title":"An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"2021061821300696600_keab166-B87","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/gyno.1997.4666","article-title":"Serum CA-125 screening for ovarian cancer in patients with dermatomyositis","volume":"65","author":"Whitmore","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2021061821300696600_keab166-B88","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"2021061821300696600_keab166-B89","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2021061821300696600_keab166-B90","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutarylcoenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821300696600_keab166-B91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1346-8138.14758","article-title":"Clinical value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis","volume":"46","author":"Motegi","year":"2019","journal-title":"J Dermatol"},{"key":"2021061821300696600_keab166-B92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2018.10.021","article-title":"Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis","volume":"49","author":"Kundrick","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2021061821300696600_keab166-B93","first-page":"608","article-title":"Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET\/CT examinations","volume":"46","author":"Brix","year":"2005","journal-title":"J Nucl Med"},{"key":"2021061821300696600_keab166-B94","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa801","article-title":"Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre","author":"Loarce-Martos","year":"2020","journal-title":"Rheumatology"},{"key":"2021061821300696600_keab166-B95","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"2021061821300696600_keab166-B96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab166\/36890017\/keab166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2615\/38695068\/keab166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2615\/38695068\/keab166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:53:14Z","timestamp":1697863994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2615\/6143039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":96,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,18]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab166","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,2,18]]}}}